Annalakshmi Jagatheesan

Annalakshmi Jagatheesan currently serves as the Director of Clinical Strategy for Biosimilars and Innovative Products at Cipla, a position held since December 2022. Prior to this, Annalakshmi held roles at Viatris from November 2020 to December 2022, including Assistant General Manager and Senior Manager. Experience also includes a tenure at Mylan from September 2016 to November 2020, where Annalakshmi was Senior Manager and Manager. Additional positions include Deputy Manager in Global Clinical Sciences at IQVIA, Associate Manager, and clinical roles at St Johns Medical College and Apollo Hospitals. Annalakshmi holds a Doctor of Medicine in Pharmacology from St. Johns Medical College and a Bachelor of Medicine, Bachelor of Surgery from Tirunelveli Medical College.